{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:19:01Z","timestamp":1795144741943,"version":"4.10.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57071-7","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T21:35:57Z","timestamp":1740087357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Ameba-inspired strategy enhances probiotic efficacy via prebound nutrient supply"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-4387","authenticated-orcid":false,"given":"Chao","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaorong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4579-994X","authenticated-orcid":false,"given":"Yong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"57071_CR1","doi-asserted-by":"crossref","unstructured":"Li, C., Wang, Z. X., Xiao, H. & Wu, F. G. Intestinal delivery of probiotics: materials, strategies, and applications. Adv. Mater. e2310174 (2024).","DOI":"10.1002\/adma.202310174"},{"key":"57071_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ibd\/izy327","volume":"25","author":"KO Chudy-Onwugaje","year":"2018","unstructured":"Chudy-Onwugaje, K. O., Christian, K. E., Farraye, F. A. & Cross, R. K. A state-of-the-art review of new and emerging therapies for the treatment of IBD. Inflamm. Bowel Dis. 25, 820\u2013830 (2018).","journal-title":"Inflamm. Bowel Dis."},{"key":"57071_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41565-023-01346-x","volume":"18","author":"F Cao","year":"2023","unstructured":"Cao, F. et al. Artificial-enzymes-armed bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis. Nat. Nanotechnol. 18, 617\u2013627 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"57071_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0140-6736(17)30566-4","volume":"390","author":"G Rook","year":"2017","unstructured":"Rook, G. et al. Evolution, human-microbe interactions, and life history plasticity. Lancet 390, 521\u2013530 (2017).","journal-title":"Lancet"},{"key":"57071_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nchembio.741","volume":"8","author":"H Ashida","year":"2012","unstructured":"Ashida, H. et al. Bacteria and host interactions in the gut epithelial barrier. Nat. Chem. Biol. 8, 36\u201345 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"57071_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fmed.2018.00304","volume":"5","author":"HC Mirsepasi-Lauridsen","year":"2018","unstructured":"Mirsepasi-Lauridsen, H. C. et al. Disease-specific enteric microbiome dysbiosis in inflammatory bowel disease. Front. Med. 5, 304 (2018).","journal-title":"Front. Med."},{"key":"57071_CR7","doi-asserted-by":"publisher","first-page":"eabp9960","DOI":"10.1126\/science.abp9960","volume":"377","author":"JY Lee","year":"2022","unstructured":"Lee, J. Y., Tsolis, R. M. & B\u00e4umler, A. J. The microbiome and gut homeostasis. Science 377, eabp9960 (2022).","journal-title":"Science"},{"key":"57071_CR8","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1126\/science.aad9359","volume":"352","author":"LV Blanton","year":"2016","unstructured":"Blanton, L. V. et al. Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics. Science 352, 1533 (2016).","journal-title":"Science"},{"key":"57071_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf1283","volume":"9","author":"HL Schreiber","year":"2017","unstructured":"Schreiber, H. L. et al. Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections. Sci. Transl. Med. 9, eaaf1283 (2017).","journal-title":"Sci. Transl. Med."},{"key":"57071_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.196","volume":"2","author":"VP O\u2019Brien","year":"2016","unstructured":"O\u2019Brien, V. P. et al. A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease. Nat. Microbiol. 2, 16196 (2016).","journal-title":"Nat. Microbiol."},{"key":"57071_CR11","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1126\/science.abc3965","volume":"369","author":"JA Wargo","year":"2020","unstructured":"Wargo, J. A. Modulating gut microbes. Science 369, 1302\u20131303 (2020).","journal-title":"Science"},{"key":"57071_CR12","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bende","year":"2023","unstructured":"Bende, M. J. et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell 186, 1846\u20131862 (2023).","journal-title":"Cell"},{"key":"57071_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mattod.2022.07.014","volume":"58","author":"D-W Zheng","year":"2022","unstructured":"Zheng, D.-W. et al. A seed-like hydrogel with metabolic cascade microbiota for oral treatment of liver failure. Mater. Today 58, 30\u201340 (2022).","journal-title":"Mater. Today"},{"key":"57071_CR14","doi-asserted-by":"publisher","first-page":"17057","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole, P. W., Marchesi, J. R. & Hill, C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2, 17057 (2017).","journal-title":"Nat. Microbiol."},{"key":"57071_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41551-022-00994-z","volume":"7","author":"L Wang","year":"2023","unstructured":"Wang, L. & Liu, J. Localized butyrate restores gut homeostasis. Nat. Biomed. Eng. 7, 3\u20135 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"57071_CR16","doi-asserted-by":"publisher","first-page":"114443","DOI":"10.1016\/j.addr.2022.114443","volume":"188","author":"F Wu","year":"2022","unstructured":"Wu, F. & Liu, J. Decorated bacteria and the application in drug delivery. Adv. Drug Deliv. Rev. 188, 114443 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"57071_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202207890","volume":"35","author":"J Xu","year":"2023","unstructured":"Xu, J. et al. Probiotic-inspired nanomedicine restores intestinal homeostasis in colitis by regulating redox balance, immune responses, and the gut microbiome. Adv. Mater. 35, e2207890 (2023).","journal-title":"Adv. Mater."},{"key":"57071_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41579-023-00877-3","volume":"21","author":"WPJ Smith","year":"2023","unstructured":"Smith, W. P. J., Wucher, B. R., Nadell, C. D. & Foster, K. R. Bacterial defences: mechanisms, evolution and antimicrobial resistance. Nat. Rev. Microbiol. 21, 519\u2013534 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"57071_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.148120","volume":"480","author":"C Pan","year":"2023","unstructured":"Pan, C. et al. Bioorthogonal chemistry mediated cell engineering for advanced cell and cell-derived vesicle therapies: Principles, progresses, and remaining challenges. Chem. Eng. J 480, 148120 (2023).","journal-title":"Chem. Eng. J"},{"key":"57071_CR20","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1021\/acsnano.1c09681","volume":"16","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Physiologically inspired mucin coated Escherichia coli Nissle 1917 enhances biotherapy by regulating the pathological microenvironment to improve intestinal colonization. ACS Nano 16, 4041\u20134058 (2022).","journal-title":"ACS Nano"},{"key":"57071_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202007379","volume":"33","author":"C Pan","year":"2021","unstructured":"Pan, C. et al. Polymerization-mediated multifunctionalization of living cells for enhanced cell-based therapy. Adv. Mater. 33, 2007379 (2021).","journal-title":"Adv. Mater."},{"key":"57071_CR22","doi-asserted-by":"publisher","first-page":"2002406","DOI":"10.1002\/adma.202002406","volume":"32","author":"P Feng","year":"2020","unstructured":"Feng, P., Cao, Z., Wang, X., Li, J. & Liu, J. On-demand bacterial reactivation by restraining within a triggerable nanocoating. Adv. Mater. 32, 2002406 (2020).","journal-title":"Adv. Mater."},{"key":"57071_CR23","doi-asserted-by":"publisher","first-page":"13261","DOI":"10.1021\/jacs.3c02682","volume":"145","author":"C Pan","year":"2023","unstructured":"Pan, C. et al. In situ polymerization-mediated antigen presentation. J. Am. Chem. Soc. 145, 13261\u201313272 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"57071_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41551-020-0582-1","volume":"4","author":"D-W Zheng","year":"2020","unstructured":"Zheng, D.-W. et al. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure. Nat. Biomed. Eng. 4, 853\u2013862 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"57071_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202301349","volume":"35","author":"L Jin","year":"2023","unstructured":"Jin, L. et al. Microenvironment-activated nanozyme-armed bacteriophages efficiently combat bacterial infection. Adv. Mater. 35, 2301349 (2023).","journal-title":"Adv. Mater."},{"key":"57071_CR26","doi-asserted-by":"publisher","first-page":"e00007","DOI":"10.1128\/MMBR.00007-19","volume":"83","author":"QR Ducarmon","year":"2019","unstructured":"Ducarmon, Q. R. et al. Gut microbiota and colonization resistance against bacterial enteric infection. Microbiol. Mol. Biol. Rev. 83, e00007\u2013e00019 (2019).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"57071_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41579-022-00745-6","volume":"20","author":"CC Murdoch","year":"2022","unstructured":"Murdoch, C. C. & Skaar, E. P. Nutritional immunity: the battle for nutrient metals at the host-pathogen interface. Nat. Rev. Microbiol 20, 657\u2013670 (2022).","journal-title":"Nat. Rev. Microbiol"},{"key":"57071_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrmicro2259","volume":"8","author":"ME Hibbing","year":"2010","unstructured":"Hibbing, M. E., Fuqua, C., Parsek, M. R. & Peterson, S. B. Bacterial competition: surviving and thriving in the microbial jungle. Nat. Rev. Microbiol 8, 15\u201325 (2010).","journal-title":"Nat. Rev. Microbiol"},{"key":"57071_CR29","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s00394-021-02503-5","volume":"60","author":"XF Zhang","year":"2021","unstructured":"Zhang, X. F. et al. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis. Eur. J. Nutr. 60, 2855\u20132875 (2021).","journal-title":"Eur. J. Nutr."},{"key":"57071_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0494-4","volume":"6","author":"JA Krumbeck","year":"2018","unstructured":"Krumbeck, J. A. et al. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome 6, 121 (2018).","journal-title":"Microbiome"},{"key":"57071_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nature09668","volume":"469","author":"DA Brock","year":"2011","unstructured":"Brock, D. A., Douglas, T. E., Queller, D. C. & Strassmann, J. E. Primitive agriculture in a social amoeba. Nature 469, 393\u2013396 (2011).","journal-title":"Nature"},{"key":"57071_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1126\/science.aat2058","volume":"361","author":"C Dinh","year":"2018","unstructured":"Dinh, C. et al. Lectins modulate the microbiota of social amoebae. Science 361, 402\u2013406 (2018).","journal-title":"Science"},{"key":"57071_CR33","doi-asserted-by":"publisher","first-page":"e01866","DOI":"10.1128\/AEM.01866-20","volume":"87","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. The ecology and evolution of amoeba-bacterium interactions. Appl. Environ. Microbiol. 87, e01866\u2013e01820 (2021).","journal-title":"Appl. Environ. Microbiol."},{"key":"57071_CR34","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3390\/nu13093211","volume":"13","author":"H-Y Li","year":"2021","unstructured":"Li, H.-Y. et al. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients 13, 3211 (2021).","journal-title":"Nutrients"},{"key":"57071_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34883-5","volume":"13","author":"Z Qiao","year":"2022","unstructured":"Qiao, Z. et al. Biomimetic electrodynamic nanoparticles comprising ginger-derived extracellular vesicles for synergistic anti-infective therapy. Nat. Commun. 13, 7164 (2022).","journal-title":"Nat. Commun."},{"key":"57071_CR36","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1039\/D3MA00856H","volume":"5","author":"F Bahri","year":"2024","unstructured":"Bahri, F. et al. A comprehensive review on ginger-derived exosome-like nanoparticles as feasible therapeutic nano-agents against diseases. Mater. Adv. 5, 1846\u20131867 (2024).","journal-title":"Mater. Adv."},{"key":"57071_CR37","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chom.2018.10.001","volume":"24","author":"Y Teng","year":"2018","unstructured":"Teng, Y. et al. Plant-derived exosomal microRNAs shape the gut microbiota. Cell Host Microbe 24, 637\u2013652 (2018).","journal-title":"Cell Host Microbe"},{"key":"57071_CR38","first-page":"53","volume":"17","author":"J Kim","year":"2022","unstructured":"Kim, J., Li, S., Zhang, S. & Wang, J. Plant-derived exosome-like nanoparticles and their therapeutic activities. Asian J. Pharm. Sci. 17, 53\u201369 (2022).","journal-title":"Asian J. Pharm. Sci."},{"key":"57071_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104006","volume":"9","author":"J Li","year":"2022","unstructured":"Li, J. et al. Polydopamine nanoparticle-mediated dopaminergic immunoregulation in colitis. Adv. Sci. 9, e2104006 (2022).","journal-title":"Adv. Sci."},{"key":"57071_CR40","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.biopha.2016.07.001","volume":"83","author":"Y Gamallat","year":"2016","unstructured":"Gamallat, Y. et al. Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed. Pharmacother. 83, 536\u2013541 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"57071_CR41","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v4.28713","volume":"4","author":"X Zhuang","year":"2015","unstructured":"Zhuang, X. et al. Ginger-derived nanoparticles protect against alcohol-induced liver damage. J. Extracell. Vesicles 4, 28713 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"57071_CR42","doi-asserted-by":"publisher","first-page":"18653","DOI":"10.1021\/acsnano.1c09951","volume":"15","author":"F Centurion","year":"2021","unstructured":"Centurion, F. et al. Nanoencapsulation for probiotic delivery. ACS Nano 15, 18653\u201318660 (2021).","journal-title":"ACS Nano"},{"key":"57071_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2020.07.009","volume":"326","author":"Z Cao","year":"2020","unstructured":"Cao, Z. & Liu, J. Bacteria and bacterial derivatives as drug carriers for cancer therapy. J. Control Release 326, 396\u2013407 (2020).","journal-title":"J. Control Release"},{"key":"57071_CR44","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1136\/gut.2003.037580","volume":"53","author":"SJ Langlands","year":"2004","unstructured":"Langlands, S. J. et al. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53, 1610 (2004).","journal-title":"Gut"},{"key":"57071_CR45","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.apsb.2021.07.024","volume":"12","author":"JY Li","year":"2022","unstructured":"Li, J. Y. et al. The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery. Acta Pharm. Sin. B 12, 1460\u20131472 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"57071_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113868","volume":"175","author":"R Lin","year":"2020","unstructured":"Lin, R. et al. Lactobacillus rhamnosus GG supplementation modulates the gut microbiota to promote butyrate production, protecting against deoxynivalenol exposure in nude mice. Biochem. Pharmacol. 175, 113868 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"57071_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/pathogens8030126","volume":"8","author":"I Khan","year":"2019","unstructured":"Khan, I. et al. Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens 8, 126 (2019).","journal-title":"Pathogens"},{"key":"57071_CR48","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nature07008","volume":"453","author":"SK Mazmanian","year":"2008","unstructured":"Mazmanian, S. K. et al. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620\u2013625 (2008).","journal-title":"Nature"},{"key":"57071_CR49","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.apsb.2021.01.009","volume":"11","author":"J Shang","year":"2021","unstructured":"Shang, J. et al. Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson\u2019s disease treatment. Acta Pharm. Sin. B 11, 1213\u20131226 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"57071_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nature25172","volume":"553","author":"W Zhu","year":"2018","unstructured":"Zhu, W. et al. Precision editing of the gut microbiota ameliorates colitis. Nature 553, 208\u2013211 (2018).","journal-title":"Nature"},{"key":"57071_CR51","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","volume":"185","author":"S Federici","year":"2022","unstructured":"Federici, S. et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell 185, 2879\u20132898 (2022).","journal-title":"Cell"},{"key":"57071_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.673890","volume":"12","author":"Y Widyastuti","year":"2021","unstructured":"Widyastuti, Y. et al. Health-promoting properties of Lactobacilli in fermented dairy products. Front. Microbiol. 12, 673890 (2021).","journal-title":"Front. Microbiol."},{"key":"57071_CR53","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nm.4102","volume":"22","author":"B Lamas","year":"2016","unstructured":"Lamas, B. et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22, 598\u2013605 (2016).","journal-title":"Nat. Med."},{"key":"57071_CR54","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1136\/gut.2010.232918","volume":"60","author":"E Macho Fernandez","year":"2011","unstructured":"Macho Fernandez, E. et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60, 1050\u20131059 (2011).","journal-title":"Gut"},{"key":"57071_CR55","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","volume":"35","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunity. Cell Metab. 35, 943\u2013960.e949 (2023).","journal-title":"Cell Metab."},{"key":"57071_CR56","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41579-024-01045-x","volume":"22","author":"I Sugrue","year":"2024","unstructured":"Sugrue, I. et al. Bacteriocin diversity, function, discovery and application as antimicrobials. Nat. Rev. Microbiol. 22, 556\u2013571 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"57071_CR57","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1007\/s10753-019-01028-8","volume":"42","author":"M G\u00fcven\u00e7","year":"2019","unstructured":"G\u00fcven\u00e7, M. et al. Protective effects of tyrosol against dss-induced ulcerative colitis in rats. Inflammation 42, 1680\u20131691 (2019).","journal-title":"Inflammation"},{"key":"57071_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202207350","volume":"19","author":"Q Huang","year":"2023","unstructured":"Huang, Q. et al. Oral Metal-free melanin nanozymes for natural and durable targeted treatment of inflammatory bowel disease (IBD). Small 19, e2207350 (2023).","journal-title":"Small"},{"key":"57071_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1832857","volume":"12","author":"L Ma","year":"2020","unstructured":"Ma, L. et al. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes 12, 1\u201319 (2020).","journal-title":"Gut Microbes"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57071-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57071-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57071-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T22:19:04Z","timestamp":1740089944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57071-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57071"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57071-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1827"}}